 |
|
The First Korean case of combined oxidative phosphorylation deficiency-17 diagnosed by clinical and molecular investigation
Young A Kim (Kim YA), Yoo-Mi Kim (Kim YM), Yun-Jin Lee (Lee YJ), Chong Kun Cheon (Cheon CK)
Clin Exp Pediatr. 2017;60(12):408-412. Published online 2017 Dec 22 DOI: https://doi.org/10.3345/kjp.2017.60.12.408
|
|
Citations to this article as recorded by
 Novel ELAC2 Mutations in Individuals Presenting with Variably Severe Neurological Disease in the Presence or Absence of Cardiomyopathy
Cérane Cafournet, Sofia Zanin, Anne Guimier, Marie Hully, Zahra Assouline, Giulia Barcia, Pascale de Lonlay, Julie Steffann, Arnold Munnich, Jean-Paul Bonnefont, Agnès Rötig, Benedetta Ruzzenente, Metodi D. Metodiev
Life.2023; 13(2): 445. CrossRef Implementation of chromosomal microarrays in a cohort of patients with intellectual disability at the Argentinean public health system
Lucía Daniela Espeche, Andrea Paula Solari, María Ángeles Mori, Rubén Martín Arenas, María Palomares, Myriam Pérez, Cinthia Martínez, Vanesa Lotersztein, Mabel Segovia, Romina Armando, Liliana Beatriz Dain, Julián Nevado, Pablo Lapunzina, Sandra Rozental
Molecular Biology Reports.2020; 47(9): 6863. CrossRef Mutations inELAC2associated with hypertrophic cardiomyopathy impair mitochondrial tRNA 3′‐end processing
Makenzie Saoura, Christopher A. Powell, Robert Kopajtich, Ahmad Alahmad, Haya H. AL‐Balool, Buthaina Albash, Majid Alfadhel, Charlotte L. Alston, Enrico Bertini, Penelope E. Bonnen, Drago Bratkovic, Rosalba Carrozzo, Maria A. Donati, Michela Di Nottia, Da
Human Mutation.2019; 40(10): 1731. CrossRef
|